Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

OrthoPediatrics Corp. - Common Stock (NQ: KIDS )

27.16 +0.63 (+2.37%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about OrthoPediatrics Corp. - Common Stock

< Previous 1 2 3 4 Next >
OrthoPediatrics Corp. Reports Fourth Quarter and Full Year 2023 Financial Results
Record full year 2023 revenue of $148.7 million increased 22% compared to prior year 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches New RESPONSE Rib and Pelvic Fixation System for EOS Scoliosis
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Named One of the 2024 Best Places to Work in Indiana
From OrthoPediatrics Corp.
Via GlobeNewswire
Decoding 5 Analyst Evaluations For OrthoPediatrics
Via Benzinga
Analyst Ratings for OrthoPediatrics
Via Benzinga
Earnings Scheduled For November 6, 2023
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
Via Benzinga
4 Analysts Have This to Say About OrthoPediatrics
Via Benzinga
Earnings Scheduled For March 6, 2024
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million. 
Via Benzinga
Earnings Outlook For OrthoPediatrics
Via Benzinga
OrthoPediatrics's Earnings: A Preview
Via Benzinga
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
Issues 2024 financial guidance 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Announces Launch of Specialty Bracing Division
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Host Educational and Networking Events at 19th Annual International Pediatric Orthopaedic Symposium (IPOS)
Increases IPOS Corporate Partnership as Emerald-Level Sponsor 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate in Upcoming November Conferences
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Third Quarter 2023 Financial Results
Record Setting Quarterly Revenue of $40.0 million 
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Enters Distribution Agreement with Ora Medical
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches MP+ Bar for Clubfoot
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches Pediatric Nailing Platform | Tibia
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Report Third Quarter 2023 Financial Results on November 7, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Joins Alliance for Pediatric Device Innovation
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Launches DF2 Brace®
From OrthoPediatrics Corp.
Via GlobeNewswire
Alphabet To Rally Over 10%? Here Are 10 Other Analyst Forecasts For Wednesday
Citigroup raised the price target for LyondellBasell Industries N.V. (NYSE: LYB) from $104 to $106. Citigroup analyst Patrick Cunningham upgraded the stock from Neutral to Buy. LyondellBasell... 
Via Benzinga
OrthoPediatrics was a Gold Level Sponsor of the Scoliosis Research Society 58th Annual Meeting
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. to Participate at the Gilmartin Group Emerging Growth Company Showcase
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Receives FDA 510(k) Clearance for Pediatric Nailing Platform | Tibia
From OrthoPediatrics Corp.
Via GlobeNewswire
OrthoPediatrics Corp. Reports Second Quarter 2023 Financial Results
Record Setting Quarterly Revenue of $39.6 million 
From OrthoPediatrics Corp.
Via GlobeNewswire
Earnings Scheduled For July 31, 2023
Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million. 
Via Benzinga
OrthoPediatrics Corp. to Report Second Quarter 2023 Financial Results on August 1, 2023
From OrthoPediatrics Corp.
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.